Literature DB >> 9351452

Macrophage-dependent regulation of syndecan gene expression.

J Li1, L F Brown, R J Laham, R Volk, M Simons.   

Abstract

Heparan sulfates in the extracellular matrix are required for a variety of biological processes, including cellular response to heparin-binding growth factors. However, little is known regarding the regulation of their expression and composition under pathophysiological conditions. In the present study, we have investigated the regulation of expression of two key heparan sulfate chain-carrying core proteins, syndecan-1 and syndecan-4, in a mouse/rat infarct model of tissue injury and repair. Induction of myocardial infarction was associated with a prompt increase in expression of both syndecan genes. Although infiltrating macrophages accounted for a substantial increase in syndecan expression, increased expression was noted in the levels of syndecan-1 mRNA in endothelial cells and syndecan-4 mRNA in cardiac myocytes. This increase in expression was limited to the immediate peri-infarct region and was absent from remote areas of the left or right ventricles. The influx of blood-derived macrophages in the heart correlated with the appearance of PR-39 peptide, which has previously been shown to increase syndecan expression in vitro. Studies in the op/op mice strain (which demonstrates sharply reduced levels of circulating monocytes) showed that myocardial infarction was associated with markedly reduced levels of macrophage influx and corresponding reduction in the expression of PR-39 and both syndecan genes. Pretreatment of op/op mice with granulocyte macrophage colony-stimulating factor restored myocardial macrophage content with corresponding restoration of PR-39/syndecan expression. In summary, myocardial infarction is associated with a distinct spatial and temporal pattern of syndecan-1 and -4 gene expression, which is induced by an influx of blood-derived macrophages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351452     DOI: 10.1161/01.res.81.5.785

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  26 in total

1.  Lake Tahoe invitation meeting 2002.

Authors: 
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

2.  Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.

Authors:  Y Gao; S Lecker; M J Post; A J Hietaranta; J Li; R Volk; M Li; K Sato; A K Saluja; M L Steer; A L Goldberg; M Simons
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 4.  Fibroblast growth factor regulation of neovascularization.

Authors:  Masahiro Murakami; Michael Simons
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

5.  Cathelicidin gene expression in porcine tissues: roles in ontogeny and tissue specificity.

Authors:  H Wu; G Zhang; C R Ross; F Blecha
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  Syndecan 4 regulation of PDK1-dependent Akt activation.

Authors:  Rong Ju; Michael Simons
Journal:  Cell Signal       Date:  2012-09-10       Impact factor: 4.315

Review 7.  Syndecan-4: dispensable or indispensable?

Authors:  Sarah A Wilcox-Adelman; Fabienne Denhez; Tokuro Iwabuchi; Stefania Saoncella; Enzo Calautti; Paul F Goetinck
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 8.  Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling.

Authors:  Mark D Bass; Martin J Humphries
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  Molecular basis for proline- and arginine-rich peptide inhibition of proteasome.

Authors:  Asokan Anbanandam; Diana C Albarado; Daniela C Tirziu; Michael Simons; Sudha Veeraraghavan
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

Review 10.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.